DFO low-dose therapy
نویسندگان
چکیده
منابع مشابه
Arthritis Associated With Low Dose Methimazole Therapy: A Case Report.
Here in this paper, we report a 31-year-old case admitted with symptoms of hyperthyroidism that was then diagnosed with Grave's disease (GD) and underwent treatments with a low dosage of methimazole (10 mg/day). 20 days after treatments initiations, she developed antithyroid arthritis syndrome. This patient experienced arthritis and arthralgia in at least 4 joints. And all autoimmune and microb...
متن کاملProphylactic Low-Dose Aspirin Therapy
Background. The influence of prophylactic low-dose aspirin on the clinical characteristics of subsequent nonfatal myocardial infarction was examined in the Physicians' Health Study, a randomized, double-blind placebo-controlled trial of alternate-day aspirin (325 mg) among 22,071 US male physicians. Methods and Results. During 60.2 months of follow-up, 342 incident cases of nonfatal myocardial ...
متن کاملLactic acidosis: high-dose or low-dose bicarbonate therapy?
occurs intracellularly, extracellularly, and in the cerebrospinal fluid (CSF). Adding sodium bicarbonate to the extracellular fluid causes a decrease in hydrogen ions with subsequent increase in carbon dioxide (CO2) concentration. Since CO2) but not bicarbonate, readily diffuses across cell membranes and into the CSF, this leads to an increase in intracellular and CSF CO2 concentration, with co...
متن کاملLow dose dapsone therapy in lepromatous leprosy.
U n der the conditions of this s tudy, dapsone in d oses of 5 mg and 10 mg daily when ad ministered to p atients with lepromat ous leprosy is an ineffe ctive therapy in terms of killing and elimin ation of My co. leprae from human skin and b one marrow . A real danger of facili tating the emergence of resistant bacilli exists . Therefore , un til there is more evidence from long term therapeuti...
متن کاملLow dose naltrexone therapy in multiple sclerosis.
The use of low doses of naltrexone for the treatment of multiple sclerosis (MS) enjoys a worldwide following amongst MS patients. There is overwhelming anecdotal evidence, that in low doses naltrexone not only prevents relapses in MS but also reduces the progression of the disease. It is proposed that naltrexone acts by reducing apoptosis of oligodendrocytes. It does this by reducing inducible ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 1996
ISSN: 1460-2385,0931-0509
DOI: 10.1093/ndt/11.6.1189a